Page 47 - Formulation In Selection Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Formulation in selection program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Formulation In Selection Program Today - Breaking & Trending Today

Probiotic B. longum BB536 may prevent common cold symptoms

Daily supplementation with B. longum BB536 can suppress common cold-like symptoms in healthy adults, but future studies are required to clarify how it works, according to a new Morinaga-funded study. ....

Matsumoto City Hospital , Matsumoto City , Functional Foods , East Asia , Sian Tastes , Healthy Living , Unctional Foods And Drinks , Common Cold , Immune System ,

Streamlining drug development: Insights from Medable's Colin Weller

A conversation between Colin Weller, VP and GM of the evidence platform at Medable and Liza Laws, senior editor, at Outsourcing Pharma, was held at this year’s SCOPE 2024 in Orlando. ....

Drug Delivery , Clinical Development , Contract Manufacturing Amp Logistics , Markets Amp Regulations , Atient Centricity , Data Management , Drug Delivery , Patient Engagement , Decentralized Trials , Cope 2024 , Drug Development ,

Innovations in drug delivery: join our panel of industry experts

As the landscape of healthcare continues to evolve, so too does the field of drug delivery. ....

France General , Todd Asmuth , Gil Roth , Leucid Bio , Cameron Owen , John Maher , Pharma Biopharma Outsourcing Association , Shine Technology , Biopharma Outsourcing Association , Drug Delivery , Clinical Development , Contract Manufacturing Amp Logistics , Markets Amp Regulations , Pis Active Pharmaceutical Ingredients , Delivery Formulations , Delivery Technologies , Raw Materials And Intermediates , Coating Amp Ancillary Equipment , Contract Manufacturing , Drug Delivery , Active Ingredient ,

Cipla partners with CSIR-CDRI to develop formulation for fungal keratitis

Drug major Cipla on Thursday said it has tied up with CSIR-Central Drug Research Institute to jointly develop a novel ophthalmic formulation for fungal keratitis. The collaboration aims to leverage the combined expertise and resources of both organisations to develop a safe and efficacious drug for fungal keratitis, the Mumbai-based drug maker said in a statement. ....

Radha Rangarajan , Csir Central Drug Research Institute , Central Drug Research Institute , Csir Cdri , Fungal Keratitis ,